HLA-P and alkaline phosphatase measurement: Serum amylase (AMY) and lipase (LPS), established diagnostic biomarkers of AP that reflect pancreatic acinar cell injury and enzyme release into systemic circulation, were elevated in both BAP and HLAP patients (Ross et al., 2021).